This study aimed to evaluate the effect of tilmicosin on rabbit immunity after daily subcutaneous (S.C) injection for 3 successive days. Fifteen New Zealand male rabbits were divided into 3 groups; the first group was left as a control, the second was non treated vaccinated against pasteurellosis (1 mL S.C in the skin fold of the back of the rabbit), while, the third was vaccinated and treated by tilmicosin in a dose of 10 mg/kg BW daily for 3 days. Whole blood and serum samples were collected from each rabbit on 1 st ,3 rd ,9 th ,14 th ,21 st and 28 th days post drug administration to determine some immunological and biochemical parameters. Histopathological examination of liver, kidneys and heart of all groups was also carried out. The results revealed that tilmicosin elicited a significant increase in B-lymphocytes, nitric oxide production by macrophages and lysozyme activity of the serum. Meanwhile, the drug had no significant changes on alanine aminotransferase enzyme (ALT) and aspartate aminotransferase enzyme (AST) levels (liver enzymes). On the 21 st day ALT showed significant decrease. Moreover; there were no significant changes on urea and creatinine levels (kidney functions) when compared with control group. Histopathological findings of the vaccinated and treated groups showed lesion score from 1 st and 2 nd degree. It could be concluded that tilmicosin afforded a good effect on rabbits' immunity without negative effects on liver and kidney functions.
Introduction
Since the use of chemotherapeutic agents was widely introduced in the veterinary field, many authors have studied their influence on the immune response against animal diseases. Nonspecific immune-stimulants are gaining increased attention and attraction for medication in the veterinary field through potentiation of the immune response to applied vaccines [1] . Immunosuppressive properties of some antibiotics are represented by inhibition of both cellular and humoral immune responses to a variety of vaccines [2] .
Tilmicosin is one of the macrolide antibiotics developed for veterinary use. It is synthesized from tylosin, and has an antibacterial spectrum similar to tylosin with enhanced activity against Pasteurella multocida and Pasteurella haemolitica [3] . It acts by inhibiting protein synthesis by binding to the 50 S ribosomal subunit of sensitive microorganisms [4] . Tilmicosin is used for treating some diseases caused by tilmicosin sensitive microorganisms such as: respiratory tract infections in rabbits caused by P. multocida and Bordetella bronchiseptica as well as bacterial enteritis caused by clostridia. Moreover, Mycoplasma gallisepticum and M. synoviae are sensitive to tilmicosin [5, 6] . The aim of this study was to investigate the immunological and biochemical effects of tilmicosin in rabbits vaccinated with P. multocida.
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Material and Methods
Animals and experimental design
Tilmicosin phosphate was obtained from (ELANCO Animal Health, Eli Lilly, Geneva, Switzerland) as an aqueous solution in dark plastic bottle containing 240 mL (250 mg/mL). The molecular formula is: C 46 H 80 N 2 O 13 [7] . It was injected S.C with a dose of 10 mg/kg BW once daily for 3 successive days [8] . Formalinized killed P. multocida vaccine was obtained from Veterinary Serum and Vaccine Research Institute (VSVRI), Abassia, Cairo, Egypt. It was administrated S.C in a dose of 1 mL in the skin fold of the back of the rabbits [9] . Fifteen male New Zealand rabbits were divided into three equal groups each of five weighing about 1.5 kg/animal. Each rabbit was kept in a separate cage and fed dry pellets (150 g/rabbit twice daily). Animals in the 1 st group were kept as control, they received no drug and no vaccine all over the experimental period. Those of the 2 nd group were non treated vaccinated with formalinized killed P. multocida vaccine in a dose of 1 mL in the skin fold of the back of each animal. Rabbits in the 3 rd group were S.C injected with tilmicosin (10 mg/kg BW) once daily for 3 successive days and then vaccinated with the same vaccine at the same day in which the 2 nd group was vaccinated.
Heparinized blood samples (2 mL from the ear vein) were obtained on 1 st , 3 rd and 9 th day post vaccination from the vaccinated group and treated vaccinated group for the application of lymphocyte transformation assay [10] . For estimation of liver and kidney function tests (ALT, AST, Urea and Creatinine) and measurement of nitric oxide produced by macrophages in the serum, 3 ml of blood were collected from each rabbit on 1 st , 3 rd , 9 th , 14 th , 21 st , 28 th days [11, 12] .
Histopathological changes of liver, kidneys and heart following tilmicosin medication were investigated at the end of the experiment (28 th day). Two animals were sacrificed from each group and tissues were placed in 10% formalin solution then embedded in paraffin and stained by H&E [13] .
Analytical procedures
Serum nitric oxide level was measured with colorimetric method using Griess reagent, while serum lysozyme activity was estimated according to Schltz [12] . Lymphocyte transformation test using MTT (3-{4,5-dimethylthiazol-2-yl}-2,5-diphenyltetrazolium bromide) which was used for separation of mononuclear cells. Reactivos GPL kits was used for estimation of liver functions (ALT, AST) according to Amador and Wacker [15] and Bergmeyer [16] , respectively. Also, kidney function tests (blood urea nitrogen and creatinine) according to Tabacco [17] and Henry et al. [18] , respectively, were carried out.
Statistical analysis
The data were analyzed using SPSS version 21, IBM Corp., Chicago, IL, USA. Analysis of variance (one -way ANOVA) was used to detect the differences between treatments. Data were expressed as mean ± SD and Duncan's test was used to find the differences among means. Results with P ≤ 0.05 were considered significantly different.
Results
Immunological results
The data represented in the present study emphasized a significant increase in all the examined parameters (B-lymphocyte transformation test, nitric oxide test and lysozyme activity), when comparing the vaccinated treated and vaccinated non treated groups with control group on the 3 rd and 9 th days post vaccination. Moreover, there was a significant increase in lymphocyte transformation in vaccinated treated group compared with the vaccinated non treated one on 3 rd and 9 th day (Table 1) .
Biochemical results
The obtained results indicated that there was a significant increase in AST activity in 1 st day, 3 rd day and 9 th day of the experiment in the vaccinated and treated group compared with control group. In 14 th , 21 st and 28 th days of the experiment there was no significant changes in vaccinated, treated group compared with control group. In vaccinated non treated group, there were an increase in AST levels all over the period of experiment compared with control group, with more increase in 14 th and 21 st days than the others (Table 2 ).
There was a significant increase in the ALT activity in vaccinated and treated groups compared with the control group at 1 st (Table 2) .
Our results demonstrated a significant increase in serum creatinine level at 1 st , 3 rd and 9 th days of the experiment in vaccinated and treated group when compared with control group. At 14 th , 21 st and 28 th days, there were no significant changes in the serum creatinine levels in vaccinated and treated groups compared with the control group. In vaccinated non treated group, there were no significant changes in the serum creatinine level all over the experimental period compared with the control group (Table 2). The results of this study demonstrated a significant increase in serum urea level at 1 st , 3 rd , 9 th and 14 th days of the experiment in vaccinated and treated groups compared with the control group. At 21 st and 28 th days of the experiment, there were no significant changes in the serum urea level in vaccinated and treated group compared with the control group. In vaccinated non treated group, there was significant increase in the serum urea level all over the period of the experiment compared with the control group (Table 2). 
Histopathological results
In vaccinated non treated and vaccinated, treated groups, the histopathological changes in liver, kidneys and heart were illustrated in Figure (1 
Discussion
The present study was conducted to evaluate the effects of tilmicosin on rabbit immunity as well as to evaluate its effect on some biochemical parameters and histopathological findings. The results of this study revealed that the vaccinated rabbits when treated S.C with tilmicosin (10 mg/Kg BW/day) for 3 successive days showed no significant changes in the serum urea level, ALT and AST levels compared with the control group. These findings were confirmed by Xie et al. [19] , Jordan [20] , Jordan [21] and Altunok et al. [22] . The authors stated that liver function parameters such as ALT, urea and AST were normal, suggesting that the damage of liver was slight and reversible and no tilmicosin treatment-related changes occurred in creatinine. However, Jordan [21] observed that serum ALT after high-dose of tilmicosin in dogs of both sexes was increased by day 12 and continued to increase to the end of the study. This could be attributed to different species under investigation. In the present study, histopathological findings in treated rabbits with tilmicosin showed lesion scores of 1 st and 2 nd degree (on a scale of 0 to 3) according to Done [23] . These findings were incompatible with Jordan [20] who observed small foci of myocardial necrosis in the papillary muscle as a sign of toxicity. Also, Christodoulopoules [24] reported that lambs injected S.C with tilmicosin 15 mg/kg BW died within 15 minutes.
During necropsy, the heart was found to have multiple ventricular septal defects. Death was attributed to sudden heart failure due to the effects of tilmicosin on the heart. Regarding the effect of tilmicosin on lysozyme activity, this study clearly demonstrated that lysozyme activity increased in the treatedvaccinated group and vaccinated non treated group with maximum levels at 9 th day of the experiment. This result was confirmed by Scorneaux and Shryock [25] who reported that tilmicosin enhanced intracellular killing by phagocytes which were detected in studies using swine phagocytes.
Tilmicosin uptake increased the lysosomal enzymes (acid phosphatase, lysozyme and beta-glucuronidas) production. In this study, nitric oxide level in serum was increased in treated and vaccinated groups. This result was in agreement with Cao et al. [26] who reported that tilmicosin decreased nitric oxide production. The promotion of B-lymphocytes proliferation in the treated group is compatible with Yun et al. [27] who reported that tilmicosin was similar to those of negative control whether in vitro or in vivo, indicating that this antibiotic did not promote or inhibit lymphocyte proliferation. In our study, tilmicosin stimulated humoral immune response which was inconsistent with Khalifeh et al. [28] who reported that tilmicosin reduced the humoral immune response. Also, Guan et al. [29] suggested that tilmicosin could suppress the humoral immune response.
Conclusion
Summing up our observations, tilmicosin elicited a significant increase in B-lymphocyte transformation, nitric oxide level and lysozyme activity. Thus indicating its immune stimulation effects with mild reversible impact on liver and kidney functions. The combination of formalinized killed P. multocida vaccine and tilmicosin in the prevention and treatment of rabbit pasteurollosis is more effective than using one of them alone. 
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